We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Objectives
- Hypersensitivity reactions
- Does autoimmunity exist?
- Prevalence of autoimmune diseases
- Overview of the immune response
- Before we get started
- Key players in hypersensitivity reactions 1: Antibody
- Key players in hypersensitivity reactions 2: Complement
- Effects of complement activation
- Effects of complement activation: Direct killing
- Effects of complement activation: Chemotaxis
- Complement activation can result in increased traffic to the site of activation
- Complement activation results in the formation of opsonins
- Reminder - what are opsonins?
- Complement fragments act to solubilise immune complexes
- Effects of complement activation
- Classification of hypersensitivity reactions
- Gel and Coomb’s classification: Type I
- Gel and Coomb’s classification: Type II
- Type II hypersensitivity: Direct cell killing
- Let’s review an example
- Haemolytic anaemia: Antibodies to red blood cell antigens
- Haemolytic anaemia: Complement activation
- Which of these functions play a role in type II hypersensitivity reactions?
- Three functions play a role in type II hypersensitivity reactions
- Complement activation
- Effects of complement activation
- Direct killing and type II hypersensitivity reactions
- Direct killing of red blood cells (or encapsulated bacteria)
- Type II hypersensitivity reaction
- Effects of complement activation: Opsonisation
- Type II hypersensitivity reaction: Phagocytosis
- Phagocytosis by macrophages
- Type II hypersensitivity: Clinical examples
- Type II hypersensitivity: ABO transfusion reactions
- Basis of ABO blood groups
- The ABO blood group system
- ABO transfusion reactions (1)
- ABO transfusion reactions (2)
- Immediate haemolytic transfusion reaction
- Type II hypersensitivity: Clinical examples
- Haemolytic disease of the newborn (1)
- Haemolytic disease of the newborn (2)
- Haemolytic disease of the newborn: Hydrops fetalis
- Type II hypersensitivity: Disease is caused by autoantibodies to cell surface proteins
- Subtype of type II hypersensitivity: Activating antibodies
- How could you prove that a disease is mediated by autoantibodies?
- Type II hypersensitivity: Management
- Gel and Coomb’s classification: Type III
- Type III hypersensitivity reactions
- Immune complex deposition
- Inflammation
- Type III hypersensitivity can be local or general
- Acute hypersensitivity pneumonitis: Pigeon fancier’s lung
- Causes of hypersensitivity pneumonitis
- Can you explain the clinical features of acute hypersensitivity pneumonitis?
- Type III hypersensitivity can be local or general
- Immune complex deposition results in small-vessel vasculitis
- Diagnosis of type III hypersensitivity reactions
- Type III hypersensitivity reactions: Management
- Gel and Coomb’s classification: Type IV
- Type IV hypersensitivity: Delayed-type hypersensitivity
- Type IV hypersensitivity: Nickel hypersensitivity
- Type IV hypersensitivity
- Investigation of contact dermatitis
- Investigations
- Management
- Diseases associated with delayed-type hypersensitivity reactions
- Sarcoidosis (1)
- Sarcoidosis is a multisystem disorder
- Sarcoidosis is characterised by granuloma
- So what’s a granuloma?
- Sarcoidosis (2)
- Management of sarcoidosis
- Diseases characterised by type IV hypersensitivity and granuloma formation
- Types of hypersensitivity reactions and the components of the immune system involved
- Thanks for listening!
Topics Covered
- Hypersensitivity reactions
- Classifying hypersensitivity disorders
- Immunological mechanisms of hypersensitivity disorders
- Components of the immune system and hypersensitivity reactions
- Management of hypersensitivity
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Marshall, S. (2021, November 28). Hypersensitivity diseases: type II-IV hypersensitivity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 6, 2024, from https://doi.org/10.69645/UJSV5915.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Sara Marshall has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Sara Marshall and I'm an Honorary Professor of Clinical Immunology at
the University of Dundee and
Head of Clinical and Physiological Sciences at the Wellcome Trust.
My talk today is titled Hypersensitivity.
0:16
My objectives for this talk are firstly to
review the classification of hypersensitivity disorders,
to appreciate and describe the immunological mechanisms that
underlie the different types of hypersensitivity disorders and diseases,
and to describe how
these different immunological mechanisms
influenced treatment options for these conditions.
0:40
First of all, let's define what a hypersensitivity reaction is.
The classic definition is that a hypersensitivity reaction is
an immune response that results in bystander damage to the self.
It's usually an exaggeration of normal immune mechanisms.
It's the important pathophysiological basis for many diseases,
including the diseases of allergy and autoimmunity.
1:09
Let's just start with the fundamental question which is, does autoimmunity exist?
You may wonder why we asked this question at all.
But, at the beginning of the 20th century,
it was thought that autoimmunity was impossible.
Ehrlich who went on to get the Nobel Prize found that
he was unable to immunize animals against self tissue.
He surmised that autoimmunity was, in fact,
impossible and he described it as "horror autotoxicus."
Now in the 1940s-1950s,
it became clear that autoimmunity did, in fact,
occur and was present in some human diseases.
Now, the first autoimmune disease to be described was autoimmune hemolytic anemia,
where the autoimmunity is against red blood cells.
Subsequently, with Witebsky and Rose,
Witebsky was a student of Ehrlich's and they described that immunization of rabbits
with a rabbit hormone would result in antibodies and inflammation.
Now, things have progressed since then, and at the moment,
we think that up to 5 percent of the population is affected by an autoimmune disease.
These conditions that are associated with hypersensitivity reactions are very common.